Peter Greenleaf, Director: Pelthos Therapeutics PTHS Sell · Filed 04/06

Trade details

Type: Insider sale
Amount: $8,618.4
Shares · price: 420 sh · $20.52 a share
Held after: 25,058 sh
Stock: Pelthos Therapeutics PTHS
Person: Peter GreenleafDirector
Trade date: 26/04/02
Filed: 26/04/06
Days to filing: 4 days

Sold 1.6% of holdings

Share of holding sold: 1.6%

Pelthos Therapeutics trades, last 26 weeks

What else happened in Pelthos Therapeutics around then

Filed or reported within 30 days of the trade day · 03/03~05/02

Peter Greenleaf's recent trades

Peter GreenleafFormer Affiliate
Planned saleAurinia Pharmaceuticals
Planned sale
Aurinia Pharmaceuticals
AUPH
$49.7M
3,136,201 sh
$49.7M
Filed 05/11
Traded 05/11
Peter GreenleafDirector
Sell10b5-1 planPelthos Therapeutics
Sell10b5-1 plan
Pelthos Therapeutics
PTHS
$8,053
377 sh
$8,053
Filed 04/06
Traded 04/02
Peter GreenleafCEO
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$1.6M
195,593 sh
$1.6M
Filed 25/03/04
Traded 25/03/03
Peter GreenleafCEO
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$1.3M
164,947 sh
$1.3M
Filed 25/03/04
Traded 25/03/04
Peter GreenleafCEO
SellAurinia Pharmaceuticals
Sell
Aurinia Pharmaceuticals
AUPH
$711.1K
126,981 sh
$711.1K
Filed 24/03/07
Traded 24/03/06